Carrasco-Hernández, L.; Quintana-Gallego, E.; Calero, C.; Reinoso-Arija, R.; Ruiz-Duque, B.; López-Campos, J.L.
Dysfunction in the Cystic Fibrosis Transmembrane Regulator in Chronic Obstructive Pulmonary Disease as a Potential Target for Personalised Medicine. Biomedicines 2021, 9, 1437.
https://doi.org/10.3390/biomedicines9101437
AMA Style
Carrasco-Hernández L, Quintana-Gallego E, Calero C, Reinoso-Arija R, Ruiz-Duque B, López-Campos JL.
Dysfunction in the Cystic Fibrosis Transmembrane Regulator in Chronic Obstructive Pulmonary Disease as a Potential Target for Personalised Medicine. Biomedicines. 2021; 9(10):1437.
https://doi.org/10.3390/biomedicines9101437
Chicago/Turabian Style
Carrasco-Hernández, Laura, Esther Quintana-Gallego, Carmen Calero, Rocío Reinoso-Arija, Borja Ruiz-Duque, and José Luis López-Campos.
2021. "Dysfunction in the Cystic Fibrosis Transmembrane Regulator in Chronic Obstructive Pulmonary Disease as a Potential Target for Personalised Medicine" Biomedicines 9, no. 10: 1437.
https://doi.org/10.3390/biomedicines9101437
APA Style
Carrasco-Hernández, L., Quintana-Gallego, E., Calero, C., Reinoso-Arija, R., Ruiz-Duque, B., & López-Campos, J. L.
(2021). Dysfunction in the Cystic Fibrosis Transmembrane Regulator in Chronic Obstructive Pulmonary Disease as a Potential Target for Personalised Medicine. Biomedicines, 9(10), 1437.
https://doi.org/10.3390/biomedicines9101437
